Legal & General Group’s Virax Biolabs VRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,976
Closed -$68.4K 3522
2023
Q1
$68.4K Sell
9,976
-285
-3% -$1.95K ﹤0.01% 2830
2022
Q4
$73.5K Buy
+10,261
New +$73.5K ﹤0.01% 2877